| Primary |
| Hypertension |
30.5% |
| Product Used For Unknown Indication |
27.1% |
| Cardiac Failure |
6.9% |
| Hypertension Arterial |
5.7% |
| Drug Use For Unknown Indication |
5.0% |
| Acute Coronary Syndrome |
3.1% |
| Essential Hypertension |
3.1% |
| Atrial Fibrillation |
1.9% |
| Myocardial Infarction |
1.9% |
| Cardiovascular Event Prophylaxis |
1.5% |
| Depressive Symptom |
1.5% |
| Diabetes Mellitus |
1.5% |
| Lupus Nephritis |
1.5% |
| Prophylaxis |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Hypothyroidism |
1.1% |
| Pain |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Acute Myocardial Infarction |
0.8% |
|
| Renal Failure Acute |
20.0% |
| Renal Failure |
9.2% |
| Vomiting |
7.7% |
| Hyponatraemia |
6.2% |
| Cough |
4.6% |
| Hypertensive Crisis |
4.6% |
| Presyncope |
4.6% |
| Rash Maculo-papular |
4.6% |
| Tongue Oedema |
4.6% |
| Encephalopathy |
3.1% |
| Interstitial Lung Disease |
3.1% |
| Malaise |
3.1% |
| Pancytopenia |
3.1% |
| Pulmonary Fibrosis |
3.1% |
| Renal Failure Chronic |
3.1% |
| Swollen Tongue |
3.1% |
| Throat Tightness |
3.1% |
| Thrombocytopenia |
3.1% |
| Thrombocytopenic Purpura |
3.1% |
| Thrombosis In Device |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.7% |
| Hypertension |
16.3% |
| Product Used For Unknown Indication |
12.9% |
| Unevaluable Event |
7.7% |
| Cardiac Failure |
5.8% |
| Essential Hypertension |
4.2% |
| Diabetes Mellitus |
2.5% |
| Atrial Fibrillation |
2.3% |
| Type 2 Diabetes Mellitus |
2.2% |
| Hypercholesterolaemia |
1.8% |
| Prophylaxis |
1.4% |
| Hypertensive Heart Disease |
1.3% |
| Anxiety |
1.3% |
| Myocardial Infarction |
1.3% |
| Arrhythmia |
1.2% |
| Ischaemic Cardiomyopathy |
1.2% |
| Coronary Arterial Stent Insertion |
1.0% |
| Gout |
1.0% |
| Prophylaxis Against Transplant Rejection |
1.0% |
| Hypothyroidism |
0.9% |
|
| Renal Failure Acute |
19.7% |
| Vomiting |
9.6% |
| Thrombocytopenia |
7.1% |
| Renal Failure |
6.3% |
| Hyponatraemia |
5.4% |
| Syncope |
5.0% |
| Toxic Skin Eruption |
4.6% |
| Neutropenia |
4.2% |
| Weight Decreased |
4.2% |
| Aplastic Anaemia |
3.3% |
| Eosinophilic Pneumonia |
3.3% |
| Orthostatic Hypotension |
3.3% |
| Pancreatitis Acute |
3.3% |
| Presyncope |
3.3% |
| Rash Maculo-papular |
3.3% |
| Tongue Oedema |
3.3% |
| Toxic Epidermal Necrolysis |
2.9% |
| Hyperkalaemia |
2.5% |
| Hypotension |
2.5% |
| Interstitial Lung Disease |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.2% |
| Product Used For Unknown Indication |
18.2% |
| Hypertension |
16.3% |
| Prophylaxis |
4.6% |
| Atrial Fibrillation |
3.8% |
| Diabetes Mellitus |
3.5% |
| Rheumatoid Arthritis |
2.9% |
| Myocardial Ischaemia |
2.4% |
| Hypercholesterolaemia |
2.3% |
| Hiv Infection |
2.3% |
| Myocardial Infarction |
2.3% |
| Cardiac Failure |
2.3% |
| Type 2 Diabetes Mellitus |
2.0% |
| Ischaemic Cardiomyopathy |
1.9% |
| Pain |
1.9% |
| Thrombosis Prophylaxis |
1.7% |
| Depression |
1.7% |
| Osteoporosis |
1.5% |
| Neuralgia |
1.1% |
| Multiple Myeloma |
1.0% |
|
| Renal Failure Acute |
12.4% |
| Vomiting |
10.8% |
| Thrombocytopenia |
9.2% |
| Renal Failure |
8.4% |
| International Normalised Ratio Increased |
5.6% |
| Myocardial Infarction |
5.2% |
| Rectal Haemorrhage |
4.6% |
| Pyrexia |
4.2% |
| Rhabdomyolysis |
4.2% |
| Malaise |
3.6% |
| Somnolence |
3.4% |
| Subdural Haematoma |
3.4% |
| Tachycardia |
3.4% |
| Weight Decreased |
3.4% |
| Pulmonary Embolism |
3.2% |
| Syncope |
3.2% |
| Hypoglycaemia |
3.0% |
| Pleural Effusion |
3.0% |
| Renal Failure Chronic |
3.0% |
| Renal Impairment |
3.0% |
|
| Interacting |
| Hypertension |
28.5% |
| Drug Use For Unknown Indication |
18.5% |
| Cardiac Failure |
6.2% |
| Prophylaxis Against Hiv Infection |
6.2% |
| Sciatica |
6.2% |
| Essential Hypertension |
5.4% |
| Multiple Myeloma |
4.6% |
| Ischaemic Cardiomyopathy |
3.1% |
| Myocardial Ischaemia |
3.1% |
| Osteoarthritis |
3.1% |
| Partial Seizures |
3.1% |
| Type 2 Diabetes Mellitus |
2.3% |
| Atrial Fibrillation |
1.5% |
| Diabetes Mellitus |
1.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.5% |
| Myocardial Infarction |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Brain Metastases |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Hypertension Arterial |
0.8% |
|
| Orthostatic Hypotension |
16.7% |
| Renal Failure Acute |
11.9% |
| Hypotension |
9.5% |
| Squamous Cell Carcinoma |
7.1% |
| Syncope |
7.1% |
| Vomiting |
7.1% |
| Fall |
4.8% |
| Presyncope |
4.8% |
| Renal Failure |
4.8% |
| Vascular Resistance Systemic Increased |
4.8% |
| Walking Aid User |
4.8% |
| Blood Lactic Acid Increased |
2.4% |
| Drug Interaction |
2.4% |
| Hyperkalaemia |
2.4% |
| Thrombocytopenia |
2.4% |
| Tonic Convulsion |
2.4% |
| Varicose Ulceration |
2.4% |
| Weight Increased |
2.4% |
|
